Epic Corporation entered into a 50:50 joint venture agreement with Salem Sleep Systems Inc. to provide marketing and sales for the AcuFAB products.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
1st Jan change | Capi. | |
---|---|---|
-.--% | 20 | |
+10.93% | 6.64B | |
-28.53% | 724M | |
-42.93% | 541M | |
+69.79% | 521M | |
+181.85% | 450M | |
-47.59% | 421M | |
-.--% | 118M | |
-20.34% | 112M | |
-12.44% | 95.92M |
- Stock Market
- Equities
- EPOR Stock
- News Epic Corp.
- Epic Corporation to Form Joint Venture with Salem Sleep Systems, Inc